98%
921
2 minutes
20
The inclusion complexation behavior and the solubilization effects of Bisphenol A (BPA, an endocrine-disrupting chemical) by cyclomaltohexaose, -heptaose, and -octaose (alpha-, beta-, and gamma-cyclodextrins) were investigated by (1)H NMR spectroscopy and by elemental analysis. The results showed that beta- and gamma-cyclodextrins gave the satisfactory solubilization ability to BPA up to 7.2 x 10(3) mg L(-1) and 9.0 x 10(3) mg L(-1), respectively. X-ray crystallographic diffraction and ROESY spectroscopy were also employed to investigate the structure of the beta-CD/BPA inclusion complex in both aqueous solution and the solid state. The result showed that this complex adopted a 2:2 stoichiometry in the solid state, that is, a head-to-head beta-CD dimer accommodated two BPA molecules. The inclusion of BPA led to the desolvation of the beta-CD cavity and the destruction of the circularly closed hydrogen-bond network in the secondary side of beta-CD, which made the complex more soluble.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.carres.2008.06.018 | DOI Listing |
RSC Adv
August 2025
Department of Pharmaceutical Chemistry, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University Super Highway, Gadap Road Karachi Pakistan
The photostabilization of 5-fluorouracil (5-FU) has been carried out in the pH range of 2.0-12.0 using cyclodextrins (α-, β-, γ-) as a complexing agent.
View Article and Find Full Text PDFNanoscale
September 2025
IGCME, PCFM Lab, School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, China.
Spherical chiral polyrotaxanes (CPRs) with steerable circularly polarized luminescence (CPL) are intriguing as advanced chiroptical materials but have not been reported to date. Here, we constructed spherical chiral polyrotaxane (CPR) materials with steerable CPL by utilizing cyclodextrins (α-, β-, or γ-CyD) as the chiral wheel. Importantly, the structure and the CPL performance of the CPR materials can be regulated by varying the feeding amount and the type of cyclodextrin (α-, β-, or γ-CyD).
View Article and Find Full Text PDFMolecules
August 2025
Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago 7650568, Chile.
The escalating crisis of multidrug resistance, together with the persistence of antibiotic residues in clinical and environmental matrices, demands integrated strategies that couple sensitive detection, efficient decontamination, and controlled delivery. However, current techniques for quantifying avibactam (AVI)-a broad-spectrum β-lactamase inhibitor-such as HPLC-UV lack the sensitivity and specificity required for both therapeutic drug monitoring and environmental surveillance. Encapsulation of AVI within cyclodextrins (CDs) may simultaneously enhance its stability, bioavailability, and detectability, while the high binding affinities of CDs position them as molecular traps capable of scavenging residual AVI.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.
Niemann-Pick disease type C (NPC) is a life-threatening neurodegenerative disease caused by impaired intracellular cholesterol trafficking. A cyclic heptasaccharide, 2-hydroxypropyl-β-cyclodextrin (HP-β-CD), is currently under clinical investigation for treating NPC, but its ototoxicity remains problematic. We previously reported that β- and γ-forms of cyclodextrin (CD) derivatives with various substituents capable of accommodating/solubilizing unesterified cholesterol (UC) exerted more pronounced therapeutic and ototoxic effects when administered intracerebroventricularly than subcutaneously for NPC treatment.
View Article and Find Full Text PDFPharm Res
August 2025
Reading School of Pharmacy, University of Reading, Whiteknights, PO Box 224, Reading, RG66AD, UK.
Purpose: This study aims to evaluate the ability of various cyclodextrins (CDs) to enhance the aqueous solubility of haloperidol (HAL), through the formation of inclusion complexes. It also investigates the pharmacological activity of CD/HAL complexes using a planaria model.
Methods: Inclusion complexes were prepared using α-CD, β-CD, methyl-β-CD, hydroxypropyl-β-CD and γ-CD.